e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis
Miriam E. Abadie, Jeffrey R. Strich, Tiffany Kim, Yingda L. Xie, Kevin P. Fennelly, Kenneth N. Olivier, Meryl Waldman, Kriti Arora, Steven M. Holland, Ray Y. Chen
Source:
Eur Respir J, 50 (6) 1702023; 10.1183/13993003.02023-2017
Journal Issue:
December
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Miriam E. Abadie, Jeffrey R. Strich, Tiffany Kim, Yingda L. Xie, Kevin P. Fennelly, Kenneth N. Olivier, Meryl Waldman, Kriti Arora, Steven M. Holland, Ray Y. Chen. Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis. Eur Respir J, 50 (6) 1702023; 10.1183/13993003.02023-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Renal Fanconi syndrome with meropenem-containing regimen in drug-resistant tuberculosis
Source: Eur Respir J, 51 (3) 1702187; 10.1183/13993003.02187-2017
Year: 2018
Nephrotic syndrome associated with pulmonary tuberculosis – case presentation
Source: Eur Respir J 2007; 30: Suppl. 51, 88s
Year: 2007
Treatment options for patients with multidrug-resistant or extensively drug-resistant tuberculosis
Source: Annual Congress 2009 - Priorities in tuberculosis research
Year: 2009
Fever syndrome in AIDS and tuberculosis patient
Source: Eur Respir J 2006; 28: Suppl. 50, 128s
Year: 2006
Risk factors for treatment failure in multidrug-resistant and extensively drug-resistant tuberculosis in Estonia
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008
Acute renal failure due to rifampicin during tuberculosis treatment
Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis
Year: 2007
Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction
Source: Eur Respir Rev 2009; 18: 295-299
Year: 2009
Nontuberculous mycobacterial pneumonia associated with the triple A syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 624s
Year: 2005
Management and treatment of multidrug-resistant tuberculosis
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019
Renal failure as first manifestation of familial sarcoidosis
Source: Eur Respir J 2010; 36: 1485-1487
Year: 2010
Clinical outcomes of patients with drug-resistant and extensively drug-resistant tuberculosis in Europe
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008
Early pulmonary phenotype in Hermansky-Pudlak syndrome: Analysis of the chILD-EU registry
Source: International Congress 2016 – Paediatric bronchology I
Year: 2016
A case of resistance beyond extensively drug-resistant tuberculosis in Japan
Source: Eur Respir J 2013; 42: 870-872
Year: 2013
A case of resistance beyond extensively drug-resistant tuberculosis in Japan
Source: Eur Respir J 2013; 42: 872-873
Year: 2013
Extrapulmonary tuberculosis in patients with chronic kidney disease receiving renal replacement therapy
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Specific features of acute renal failure in rifampicin treated patients for pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 609s
Year: 2002
Hepatopulmonary syndrome in non-cirrhotic patients with chronic viral hepatitis
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
Source: Eur Respir J 2016; 47: 564-574
Year: 2016
Diabetes is associated with genotypically drug-resistant tuberculosis
Source: Eur Respir J, 55 (3) 1901891; 10.1183/13993003.01891-2019
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept